
CID-2011756
CAS No. 638156-11-3
CID-2011756( CID2011756 | CID 2011756 | CID-2011756 )
Catalog No. M15420 CAS No. 638156-11-3
CID-2011756 is a cell-active ATP competitive and specific PKD1 inhibitor that inhibits phorbol ester-induced endogenous PKD1 activation in LNCaP prostate Y cells.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 35 | In Stock |
![]() ![]() |
10MG | 65 | In Stock |
![]() ![]() |
25MG | 123 | In Stock |
![]() ![]() |
50MG | 222 | In Stock |
![]() ![]() |
100MG | 308 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameCID-2011756
-
NoteResearch use only, not for human use.
-
Brief DescriptionCID-2011756 is a cell-active ATP competitive and specific PKD1 inhibitor that inhibits phorbol ester-induced endogenous PKD1 activation in LNCaP prostate Y cells.
-
DescriptionCID-2011756 is a cell-active ATP competitive and specific PKD1 inhibitor that inhibits phorbol ester-induced endogenous PKD1 activation in LNCaP prostate Y cells.
-
In VitroCID 2011756 is an ATP-competitive PKD1 inhibitor, with an IC50 of 3.2 μM. CID 2011756 decreases the phosphorylation of endogenous PKD1 Ser916 in LNCaP cancer cells with an EC50 of 10±0.7 μM. CID 2011756 also has cellular pan-PKD inhibitory effects, with IC50s of 0.6±0.1 μM and 0.7±0.2 μM for PKD2 and PKD3, respectively.
-
In Vivo——
-
SynonymsCID2011756 | CID 2011756 | CID-2011756
-
PathwayApoptosis
-
TargetSerine/threonin kinase
-
RecptorPKD
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number638156-11-3
-
Formula Weight396.87
-
Molecular FormulaC22H21ClN2O3
-
Purity>98% (HPLC)
-
SolubilitySoluble in DMSO
-
SMILESO=C(C1=CC=C(C2=CC=CC(Cl)=C2)O1)NC3=CC=C(CN4CCOCC4)C=C3
-
Chemical Name5-(3-chlorophenyl)-N-(4-(morpholinomethyl)phenyl)furan-2-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sharlow ER, et al. PLoS One. 2011;6(10):e25134.
molnova catalog



related products
-
CRT0066101
CRT0066101 is an inhibitor of PKD.
-
PCSK9-IN-10
PCSK9-IN-10, a potent and orally active inhibitor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), exhibits a half-maximal inhibitory concentration (IC50) of 6.4 μM.
-
Chymotrypsin
Chymotrypsin (Chymotrypsin A) is a serine protease synthesized by the pancreas, which cleaves protein chains on the carboxyl side of aromatic amino acids.